{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T03:58:01Z","timestamp":1792900681437,"version":"4.5.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82473406"],"award-info":[{"award-number":["82473406"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["32201153"],"award-info":[{"award-number":["32201153"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["62275048"],"award-info":[{"award-number":["62275048"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"key Clinical Specialty Discipline Construction Program of Fuzhou, Fujian, P.R.C","award":["20230105"],"award-info":[{"award-number":["20230105"]}]},{"name":"Fuzhou Science and Technology Plan Project","award":["2023-S-021"],"award-info":[{"award-number":["2023-S-021"]}]},{"name":"Science and Technology Planning Project of Fujian Province","award":["2023J01292"],"award-info":[{"award-number":["2023J01292"]}]},{"name":"Science and Technology Planning Project of Fujian Province","award":["2021J05031"],"award-info":[{"award-number":["2021J05031"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-025-03796-y","type":"journal-article","created":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T15:18:56Z","timestamp":1763565536000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Targeting cancer stem-like cells via cholesterol modulation and ferroptosis induction using a multifunctional nanoplatform to overcome drug resistance"],"prefix":"10.1186","volume":"23","author":[{"given":"Leiguang","family":"Ye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinying","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoman","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nianhan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuemei","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shijian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuangqian","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,19]]},"reference":[{"issue":"3","key":"3796_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"3796_CR2","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s00432-010-0957-x","volume":"137","author":"TC de Ruijter","year":"2011","unstructured":"de Ruijter TC, Veeck J, de Hoon JP, van Engeland M. Tjan-Heijnen, characteristics of triple-negative breast cancer. J Cancer Res Clin Oncol. 2011;137:183\u201392.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"11","key":"3796_CR3","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/nrclinonc.2016.66","volume":"13","author":"G Bianchini","year":"2016","unstructured":"Bianchini G, Balko JM, Mayer IA, Sanders ME, Gianni L. Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease. Nat Rev Clin Oncol. 2016;13(11):674\u201390.","journal-title":"Nat Rev Clin Oncol"},{"issue":"7239","key":"3796_CR4","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1038\/nature07733","volume":"458","author":"M Diehn","year":"2009","unstructured":"Diehn M, Cho RW, Lobo NA, Kalisky T, Dorie MJ, Kulp AN, et al. Association of reactive oxygen species levels and radioresistance in cancer stem cells. Nature. 2009;458(7239):780\u20133.","journal-title":"Nature"},{"issue":"3","key":"3796_CR5","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.stem.2015.02.015","volume":"16","author":"V Plaks","year":"2015","unstructured":"Plaks V, Kong N, Werb Z. The cancer stem cell niche: how essential is the niche in regulating stemness of tumor cells? Cell Stem Cell. 2015;16(3):225\u201338.","journal-title":"Cell Stem Cell"},{"issue":"8","key":"3796_CR6","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/s41568-021-00366-w","volume":"21","author":"D Bayik","year":"2021","unstructured":"Bayik D, Lathia JD. Cancer stem cell\u2013immune cell crosstalk in tumour progression. Nat Rev Cancer. 2021;21(8):526\u201336.","journal-title":"Nat Rev Cancer"},{"issue":"22","key":"3796_CR7","doi-asserted-by":"publisher","first-page":"7856","DOI":"10.1039\/D0CS00379D","volume":"49","author":"J Han","year":"2020","unstructured":"Han J, Won M, Kim JH, Jung E, Min K, Jangili P, et al. Cancer stem cell-targeted bio-imaging and chemotherapeutic perspective. Chem Soc Rev. 2020;49(22):7856\u201378.","journal-title":"Chem Soc Rev"},{"issue":"5","key":"3796_CR8","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.stem.2024.04.004","volume":"31","author":"J-J Loh","year":"2024","unstructured":"Loh J-J, Ma S. Hallmarks of cancer stemness. Cell Stem Cell. 2024;31(5):617\u201339.","journal-title":"Cell Stem Cell"},{"issue":"1","key":"3796_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-025-07498-z","volume":"16","author":"J Deng","year":"2025","unstructured":"Deng J, Li Y, Yin L, Liu S, Li Y, Liao W, Mu L, Luo X, Qin J. Histone lactylation enhances GCLC expression and thus promotes chemoresistance of colorectal cancer stem cells through inhibiting ferroptosis. Cell Death Dis. 2025;16(1):1\u201315.","journal-title":"Cell Death Dis"},{"issue":"3","key":"3796_CR10","first-page":"358","volume":"4","author":"X Wang","year":"2025","unstructured":"Wang X, Luo J, Zeng X, Yan S. Ferroptosis by nanomaterials: targeting cancer stem cells and overcoming drug resistance. Acta Mater Med. 2025;4(3):358\u201389.","journal-title":"Acta Mater Med"},{"issue":"10","key":"3796_CR11","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1038\/s41589-024-01612-6","volume":"20","author":"Z Li","year":"2024","unstructured":"Li Z, Xu Z-m, Chen W-p, Du X-j, Ou C-x, Luo Z-k, et al. Tumor-repopulating cells evade ferroptosis via PCK2-dependent phospholipid remodeling. Nat Chem Biol. 2024;20(10):1341\u201352.","journal-title":"Nat Chem Biol"},{"issue":"7","key":"3796_CR12","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/s41568-019-0149-1","volume":"19","author":"JP Friedmann Angeli","year":"2019","unstructured":"Friedmann Angeli JP, Krysko DV, Conrad M. Ferroptosis at the crossroads of cancer-acquired drug resistance and immune evasion. Nat Rev Cancer. 2019;19(7):405\u201314.","journal-title":"Nat Rev Cancer"},{"key":"3796_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2001-1326-2-3","volume":"2","author":"LN Abdullah","year":"2013","unstructured":"Abdullah LN, Chow EK-H. Mechanisms of chemoresistance in cancer stem cells. Clin Transl Med. 2013;2:1\u20139.","journal-title":"Clin Transl Med"},{"issue":"1","key":"3796_CR14","doi-asserted-by":"publisher","DOI":"10.1002\/mog2.70009","volume":"4","author":"Y Tan","year":"2025","unstructured":"Tan Y, Qin S, Zhang Z, Liu Y, Zhou L, Li B, et al. Unraveling the underlying mechanisms of cancer stem cells in therapeutic resistance for optimizing treatment strategies. MedComm-Oncology. 2025;4(1):e70009.","journal-title":"MedComm-Oncology"},{"issue":"1","key":"3796_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-02088-5","volume":"10","author":"F Alves","year":"2025","unstructured":"Alves F, Lane D, Nguyen TPM, Bush AI, Ayton S. In defence of ferroptosis. Signal Transduct Target Ther. 2025;10(1):2.","journal-title":"Signal Transduct Target Ther"},{"issue":"5","key":"3796_CR16","doi-asserted-by":"publisher","DOI":"10.1002\/EXP.20220001","volume":"3","author":"H Lei","year":"2023","unstructured":"Lei H, Pei Z, Jiang C. Recent progress of metal-based nanomaterials with anti-tumor biological effects for enhanced cancer therapy. Exploration. 2023;3(5):20220001.","journal-title":"Exploration"},{"issue":"39","key":"3796_CR17","doi-asserted-by":"publisher","first-page":"5483","DOI":"10.1021\/acs.biochem.6b00342","volume":"55","author":"NM Cerqueira","year":"2016","unstructured":"Cerqueira NM, Oliveira EF, Gesto DS, Santos-Martins D, Moreira C, Moorthy HN, et al. Cholesterol biosynthesis: a mechanistic overview. Biochemistry. 2016;55(39):5483\u2013506.","journal-title":"Biochemistry"},{"issue":"1","key":"3796_CR18","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1038\/s41467-017-02732-5","volume":"9","author":"AK Cotte","year":"2018","unstructured":"Cotte AK, Aires V, Fredon M, Limagne E, Derang\u00e8re V, Thibaudin M, Humblin E, Scagliarini A, de Barros J-PP, Hillon P. Lysophosphatidylcholine acyltransferase 2-mediated lipid droplet production supports colorectal cancer chemoresistance. Nat Commun. 2018;9(1):322.","journal-title":"Nat Commun"},{"issue":"2","key":"3796_CR19","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2020106123","volume":"40","author":"J Lv","year":"2021","unstructured":"Lv J, Liu Y, Cheng F, Li J, Zhou Y, Zhang T, et al. Cell softness regulates tumorigenicity and stemness of cancer cells. EMBO J. 2021;40(2):e106123.","journal-title":"EMBO J"},{"key":"3796_CR20","doi-asserted-by":"crossref","unstructured":"Wu H, Wu X, Zhao M, Yan J, Li C, Zhang Z, et al. Regulating cholesterol in tumorigenesis: a novel paradigm for tumor nanotherapeutics. Int J Nanomedicine. 2024;19:1055\u20131076.","DOI":"10.2147\/IJN.S439828"},{"key":"3796_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2023.102678","volume":"62","author":"X Zhao","year":"2023","unstructured":"Zhao X, Lian X, Xie J, Liu G. Accumulated cholesterol protects tumours from elevated lipid peroxidation in the microenvironment. Redox Biol. 2023;62:102678.","journal-title":"Redox Biol"},{"key":"3796_CR22","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.ctrv.2016.10.008","volume":"52","author":"S Zalba","year":"2017","unstructured":"Zalba S, Ten TL, Hagen. Cell membrane modulation as adjuvant in cancer therapy. Cancer Treat Rev. 2017;52:48\u201357.","journal-title":"Cancer Treat Rev"},{"issue":"1","key":"3796_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-022-01406-9","volume":"20","author":"B Du","year":"2022","unstructured":"Du B, Zheng M, Ma H, Huang J, Jiao Q, Bai Y, et al. Nanozyme-natural enzymes cascade catalyze cholesterol consumption and reverse cancer multidrug resistance. J Nanobiotechnol. 2022;20(1):209.","journal-title":"J Nanobiotechnol"},{"issue":"7","key":"3796_CR24","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1038\/s41590-020-0712-7","volume":"21","author":"EV Dang","year":"2020","unstructured":"Dang EV, Madhani HD, Vance RE. Cholesterol in quarantine. Nat Immunol. 2020;21(7):716\u20137.","journal-title":"Nat Immunol"},{"key":"3796_CR25","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.phrs.2017.07.023","volume":"126","author":"MS Singh","year":"2017","unstructured":"Singh MS, Tammam SN, Boushehri MAS, Lamprecht A. MDR in cancer: addressing the underlying cellular alterations with the use of nanocarriers. Pharmacol Res. 2017;126:2\u201330.","journal-title":"Pharmacol Res"},{"issue":"19","key":"3796_CR26","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202200859","volume":"11","author":"J Guo","year":"2022","unstructured":"Guo J, Du X, Huang J, Liu C, Zhou Y, Li Y, et al. Robust dual enzyme cascade-catalytic cholesterol depletion for reverse tumor multidrug resistance. Adv Healthc Mater. 2022;11(19):2200859.","journal-title":"Adv Healthc Mater"},{"issue":"7","key":"3796_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13071556","volume":"13","author":"CF Cheng","year":"2025","unstructured":"Cheng CF, Li CH, Wang J. Effects of statins on all-cause mortality in patients with breast cancer: a population-based study. Biomedicines. 2025;13(7):1556.","journal-title":"Biomedicines"},{"key":"3796_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpc.2025.101019","volume":"23","author":"EJB Llanes","year":"2025","unstructured":"Llanes EJB, Thongtang N, Lee ZV. Addressing adherence challenges in long-term statin treatment among Asian populations: current gaps and proposed solutions. Am J Prev Cardiol. 2025;23:101019.","journal-title":"Am J Prev Cardiol"},{"issue":"2","key":"3796_CR29","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1161\/CIRCRESAHA.118.312782","volume":"124","author":"NC Ward","year":"2019","unstructured":"Ward NC, Watts GF, Eckel RH. Statin toxicity: mechanistic insights and clinical implications. Circ Res. 2019;124(2):328\u201350.","journal-title":"Circ Res"},{"issue":"22","key":"3796_CR30","doi-asserted-by":"publisher","DOI":"10.1002\/adfm.201900518","volume":"29","author":"Y Sang","year":"2019","unstructured":"Sang Y, Li W, Liu H, Zhang L, Wang H, Liu Z, et al. Construction of nanozyme-hydrogel for enhanced capture and elimination of bacteria. Adv Funct Mater. 2019;29(22):1900518.","journal-title":"Adv Funct Mater"},{"key":"3796_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.saa.2021.120045","volume":"261","author":"AFA Hakiem","year":"2021","unstructured":"Hakiem AFA, Mohamed NA, Ali HR. FTIR spectroscopic study of two isostructural statins: Simvastatin and Lovastatin as authentic and in pharmaceuticals. Spectrochim Acta A Mol Biomol Spectrosc. 2021;261:120045.","journal-title":"Spectrochim Acta A Mol Biomol Spectrosc"},{"key":"3796_CR32","doi-asserted-by":"publisher","first-page":"3439","DOI":"10.1007\/s13197-018-3253-4","volume":"55","author":"G Sundaresan","year":"2018","unstructured":"Sundaresan G, Abraham RJ, Appa Rao V, Narendra Babu R, Govind V, Meti MF. Established method of chondroitin sulphate extraction from Buffalo (Bubalus bubalis) cartilages and its identification by FTIR. J Food Sci Technol. 2018;55:3439\u201345.","journal-title":"J Food Sci Technol"},{"issue":"37","key":"3796_CR33","doi-asserted-by":"publisher","DOI":"10.1002\/adfm.202402022","volume":"34","author":"X Zhang","year":"2024","unstructured":"Zhang X, Zhu J, Wang S, Li S, E J, Hu J, et al. A copper\/ferrous-engineering redox homeostasis disruptor for cuproptosis\/ferroptosis co-activated nanocatalytic therapy in liver cancer. Adv Funct Mater. 2024;34(37):2402022.","journal-title":"Adv Funct Mater"},{"issue":"22","key":"3796_CR34","doi-asserted-by":"publisher","first-page":"5791","DOI":"10.1158\/1078-0432.CCR-20-1967","volume":"26","author":"J Longo","year":"2020","unstructured":"Longo J, van Leeuwen JE, Elbaz M, Branchard E, Penn LZ. Statins as anticancer agents in the era of precision medicine. Clin Cancer Res. 2020;26(22):5791\u2013800.","journal-title":"Clin Cancer Res"},{"issue":"3","key":"3796_CR35","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202409967","volume":"12","author":"S Yan","year":"2025","unstructured":"Yan S, Xue P, Sun Y, Bai T, Shao S, Zeng X. Cupric doping hollow Prussian blue nanoplatform for enhanced cholesterol depletion: a promising strategy for breast cancer therapy and metastasis inhibition. Adv Sci. 2025;12(3):2409967.","journal-title":"Adv Sci"},{"issue":"38","key":"3796_CR36","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202405826","volume":"11","author":"T Bai","year":"2024","unstructured":"Bai T, Xue P, Shao S, Yan S, Zeng X. Cholesterol depletion-enhanced ferroptosis and immunotherapy via engineered nanozyme. Adv Sci. 2024;11(38):2405826.","journal-title":"Adv Sci"},{"issue":"2","key":"3796_CR37","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202307752","volume":"36","author":"Y Liu","year":"2024","unstructured":"Liu Y, Niu R, Deng R, Wang Y, Song S, Zhang H. Multi-enzyme co-expressed nanomedicine for anti-metastasis tumor therapy by up-regulating cellular oxidative stress and depleting cholesterol. Adv Mater. 2024;36(2):2307752.","journal-title":"Adv Mater"},{"issue":"2","key":"3796_CR38","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/S0005-2736(03)00016-6","volume":"1610","author":"JR Silvius","year":"2003","unstructured":"Silvius JR. Role of cholesterol in lipid raft formation: lessons from lipid model systems. Biochimica et Biophysica Acta (BBA). 2003;1610(2):174\u201383.","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"issue":"40","key":"3796_CR39","doi-asserted-by":"publisher","DOI":"10.1002\/adfm.202205013","volume":"32","author":"W Xu","year":"2022","unstructured":"Xu W, Qian J, Hou G, Wang T, Wang J, Wang Y, et al. A hollow amorphous bimetal organic framework for synergistic cuproptosis\/ferroptosis\/apoptosis anticancer therapy via disrupting intracellular redox homeostasis and copper\/iron metabolisms. Adv Funct Mater. 2022;32(40):2205013.","journal-title":"Adv Funct Mater"},{"issue":"9","key":"3796_CR40","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1038\/s41556-024-01425-8","volume":"26","author":"T Nakamura","year":"2024","unstructured":"Nakamura T, Conrad M. Exploiting ferroptosis vulnerabilities in cancer. Nat Cell Biol. 2024;26(9):1407\u201319.","journal-title":"Nat Cell Biol"},{"issue":"8","key":"3796_CR41","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1038\/s41374-019-0193-1","volume":"99","author":"U-J Yun","year":"2019","unstructured":"Yun U-J, Lee J-H, Shim J, Yoon K, Goh S-H, Yi EH, et al. Anti-cancer effect of doxorubicin is mediated by downregulation of HMG-Co A reductase via inhibition of EGFR\/Src pathway. Lab Invest. 2019;99(8):1157\u201372.","journal-title":"Lab Invest"},{"issue":"36","key":"3796_CR42","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2302342120","volume":"120","author":"Y Bo","year":"2023","unstructured":"Bo Y, Zhou J, Cai K, Wang Y, Feng Y, Li W, et al. Leveraging intracellular ALDH1A1 activity for selective cancer stem-like cell labeling and targeted treatment via in vivo click reaction. Proc Natl Acad Sci U S A. 2023;120(36):e2302342120.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3796_CR43","doi-asserted-by":"publisher","DOI":"10.34133\/research.0223","volume":"6","author":"Q Wang","year":"2023","unstructured":"Wang Q, Yang T, Li S, Xu C, Wang C, Xiong Y, et al. Unimolecular self-assembled hemicyanine\u2013oleic acid conjugate acts as a novel succinate dehydrogenase inhibitor to amplify photodynamic therapy and eliminate cancer stem cells. Research. 2023;6:0223.","journal-title":"Research"},{"issue":"1","key":"3796_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-38097-1","volume":"14","author":"J Bu","year":"2023","unstructured":"Bu J, Zhang Y, Wu S, Li H, Sun L, Liu Y, et al. KK-LC-1 as a therapeutic target to eliminate ALDH+ stem cells in triple negative breast cancer. Nat Commun. 2023;14(1):2602.","journal-title":"Nat Commun"},{"issue":"12","key":"3796_CR45","doi-asserted-by":"publisher","first-page":"7909","DOI":"10.1021\/acs.nanolett.8b03828","volume":"18","author":"H Yang","year":"2018","unstructured":"Yang H, Wang Q, Li Z, Li F, Wu D, Fan M, et al. Hydrophobicity-adaptive nanogels for programmed anticancer drug delivery. Nano Lett. 2018;18(12):7909\u201318.","journal-title":"Nano Lett"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03796-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-025-03796-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03796-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T17:03:07Z","timestamp":1763571787000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-025-03796-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,19]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3796"],"URL":"https:\/\/doi.org\/10.1186\/s12951-025-03796-y","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,19]]},"assertion":[{"value":"27 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were conducted in accordance with protocols approved by the Animal Experimental Ethics Committee of Fujian Normal University (Approval No. IACUC-20230060).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"722"}}